company background image
DXCM

DexCom NasdaqGS:DXCM Stock Report

Last Price

US$87.53

Market Cap

US$34.4b

7D

-0.8%

1Y

-30.7%

Updated

18 Aug, 2022

Data

Company Financials +
DXCM fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance2/6
Financial Health5/6
Dividends0/6

DXCM Stock Overview

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.

DexCom, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for DexCom
Historical stock prices
Current Share PriceUS$87.53
52 Week HighUS$164.86
52 Week LowUS$66.89
Beta1.02
1 Month Change8.54%
3 Month Change8.99%
1 Year Change-30.75%
3 Year Change100.79%
5 Year Change363.74%
Change since IPO2,882.28%

Recent News & Updates

Aug 01
DexCom (NASDAQ:DXCM) Has A Pretty Healthy Balance Sheet

DexCom (NASDAQ:DXCM) Has A Pretty Healthy Balance Sheet

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Shareholder Returns

DXCMUS Medical EquipmentUS Market
7D-0.8%-0.4%1.4%
1Y-30.7%-21.3%-8.4%

Return vs Industry: DXCM underperformed the US Medical Equipment industry which returned -21.1% over the past year.

Return vs Market: DXCM underperformed the US Market which returned -9% over the past year.

Price Volatility

Is DXCM's price volatile compared to industry and market?
DXCM volatility
DXCM Average Weekly Movement8.1%
Medical Equipment Industry Average Movement9.5%
Market Average Movement7.6%
10% most volatile stocks in US Market17.1%
10% least volatile stocks in US Market3.1%

Stable Share Price: DXCM is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: DXCM's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19996,300Kevin Sayerhttps://www.dexcom.com

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system.

DexCom, Inc. Fundamentals Summary

How do DexCom's earnings and revenue compare to its market cap?
DXCM fundamental statistics
Market CapUS$34.36b
Earnings (TTM)US$168.00m
Revenue (TTM)US$2.67b

204.5x

P/E Ratio

12.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
DXCM income statement (TTM)
RevenueUS$2.67b
Cost of RevenueUS$906.30m
Gross ProfitUS$1.77b
Other ExpensesUS$1.60b
EarningsUS$168.00m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.43
Gross Margin66.10%
Net Profit Margin6.28%
Debt/Equity Ratio87.2%

How did DXCM perform over the long term?

See historical performance and comparison